Hardware and software specialist specializing in the food industry - Project FoodFlow

Asking price €3,000,000.00

Financial data

Turnover / Revenue €2,000,000.00
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) €600,000.00

Process automation company specializing in the food industry. A loyal and stable customer base. Exclusive licensee for Belgium. 

  • Description: Process automation company focused on the food industry. Recurring and stable customer base. Ease of use, flexibility, and high-quality service are key priorities. Various growth opportunities exist in terms of products (applications), industry, and geographic reach.
  • Organization: > 4 FTEs, a steadfast and knowledgeable team.
  • Clientele: B2B
  • Financial: Highly profitable with revenue > 2 million EUR, EBITDA > 600,000 EUR. 
  • Transaction: Sale of 100% of the shares. The owner will remain on board for a period after the transfer to ensure a smooth transition; this could last several years. Re-entry into the shares after the acquisition through a minority stake via an owner buyout is negotiable and depends on the buyer’s or investor’s vision for the future.
  • Real Estate: Leased.
  • Price: > 3 million EUR for 100% of the shares
Location
Antwerpen
Legal form
Company
Number of employees
4
Customer type
B2B (Business to Business)
Real estate included
No
Translated from
Dutch
Disclaimer
Takeover market is not responsible for the content. Please check for accuracy and completeness.

Meer van deze overnamebemiddelaar

All company advertisements
High-performing pharmacy in Flemish Brabant
Vlaams-Brabant

DaVinci Corporate Finance is facilitating the sale of an established and highly successful pharmacy in Flemish Brabant. The pharmacy boasts an excellent central location, strong customer loyalty, and a solid financial track record.The pharmacy combines traditional pharmaceutical services with custom-compounded medications and a growing focus on prevention and lifestyle counseling. Operations are already largely automated and are supported by an experienced team of pharmacists. The business also offers ample parking in the immediate vicinity.Key Figures for 2025Revenue: approx. €3.0 millionAdjusted EBITDA: approx. €436kNormalized EBITDA margin: approx. 14.6%Revenue growth over the past few yearsEstablished local market position and recurring patient baseThe transaction primarily involves the transfer of 100% of the shares in the operating company. In addition, depending on the buyer’s interest, additional pharmaceutical licenses and the commercial real estate may be included in the transaction. An additional pharmacy business operated by the sellers is also negotiable.The current shareholders will provide for a thorough handover and onboarding period to ensure the continuity of the pharmacy.Investment HighlightsStrong, historically established position in the local marketRevenue of approximately €3.0 million with attractive profitabilityCentral and easily accessible locationLarge and loyal patient baseExperienced team consisting exclusively of pharmacistsAutomated operationsFurther growth opportunities through, among other things, additional services, digitization, and commercial activationFlexible transaction scope with real estate and additional permits as potential building blocksInterested?After signing a non-disclosure agreement, additional information can be provided to qualified prospective buyers.

Price Price on request
Liberal professions

Receive our newsletter

Leave your e-mail address and stay informed of our latest updates and offers. We will gladly keep you informed of new search results and relevant information.